Cryoneurolysis Prior to Total Knee Arthroplasty
Key facts
- Who runs it
- Esbjerg Hospital - University Hospital of Southern Denmark
- Where
- Denmark1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 100 people, planned
- Started
- 30 Aug 2023
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Cryoneurolysis
- Sham
- Record updated
- 13 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 9 criteriaShow less
Who can take part
- Scheduled for unilateral, primary total knee arthroplasty
- Age ≥ 18y
- Written and oral understanding of Danish
Who cannot take part
- Contraindications against ibuprofen or paracetamol, for example previous gastric ulcer, or known renal failure (eGRF < 60 ml/kg/1,73m2), known thrombocytopenia (< 100 bil/l); or against treatment with morphine
- Previous recipient of cryoneurolysis for the knee
- History of neuropathic pain
- Uncontrolled serious disease (cancer, diabetes, etc.)
- Disease associated with reactions to cold, such as cryoglobulinemia, cold urticarial and Reynaud's syndrome
- Patients with daily use of high dose opioid (> oral morphine 30 mg/day or oxycodone 30 mg/day or tramadol 150 mg/day) or any use of other opioids including methadone and transdermal opioids
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Knee osteoarthritis is a major issue worldwide with limited treatment options. Many patients receive knee joint replacement surgery which is considered effective and safe. Nonetheless the period post-surgery is characterized by moderate to severe pain inhibiting early ambulation, motivation and range of motion, compromising rehabilitation, patient satisfaction, and overall outcomes. An optimal strategy of postoperative pain treatment after knee replacement surgery has not yet been established.
Read full original descriptionShow less
Recently, our research center and others have shown that is possible to target the nerves surrounding the knee with a novel treatment called cryoneurolysis. Cryoneurolysis apply low temperatures [-20°C ; -100°C] to a target nerve, which disrupts nerve function and provides potential pain relief. This suggest a potential for cryoneurolysis to significantly improve rehabilitation, reduce opioid intake and overall outcomes after knee replacement surgery.
The primary objective of the current project is to determine the effectiveness of cryoneurolysis in its proposed ability to reduce opioid intake and postoperative pain after knee replacement surgery.
The study is a randomized controlled study with two groups. Group CRYO receives cryoneurolysis prior to knee replacement surgery and group SHAM receives a sham treatment prior to knee replacement surgery. Both groups receive surgery, analgesics and postoperative rehabilitation as per usual.
Efficacy of treatment is evaluated using the change in opioid intake in the CRYO group compared to the SHAM group 14 days after knee replacement surgery. Participants will also be assessed at 90 and 180 days after knee replacement surgery and will include measures on pain, quality of life and function.
The 2 groups in the trial
- CRYOTreatment being tested
Receives cryoneurolysis treatment on the anterior femoral cutanous nerve and the infrapatellar branch of the saphenous nerve.
Treatment: Cryoneurolysis
- SHAMSham treatment, for comparison
Receives similar procedures as in CRYO but with no freezing temperatures.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Cryoneurolysis Prior to Total Knee Arthroplasty for the Management of Postoperative Pain; A Randomized, Sham-controlled, Trial
- Record updated
- 13 October 2026